Post-Market Clinical Investigation of NanoFUSE® Bioactive Matrix

Clinical trial NCT03762811 · UNKNOWN

Trial details

NCT number: NCT03762811
Sponsor: NanoFUSE Biologics, LLC
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Bone; Degeneration

Start date: 2019-02-01
Primary completion: 2021-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.